Eric L. Keller
CHIEF EXECUTIVE OFFICER at Retension Pharmaceuticals Inc.
Sits on 1 board. Last updated October 14, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 week
- Director since
- 2026
1 week of board service in total across 1 board, counting each seat separately. Longest: Retension Pharmaceuticals Inc., 1 week.
Retension Pharmaceuticals Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
Retension Pharmaceuticals Inc.
· CHIEF EXECUTIVE OFFICER
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 13, 2026 | Retension Pharmaceuticals Inc. | Open-market purchase | +20,800 | $12.00 | $249,600 |
| Oct 13, 2026 | Retension Pharmaceuticals Inc. | Derivative conversion | +9,662 | — | — |
| Oct 13, 2026 | Retension Pharmaceuticals Inc. | Derivative conversion | +31,368 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.